OPC 28326
Alternative Names: OPC-28326Latest Information Update: 09 Oct 2006
At a glance
- Originator Otsuka Pharmaceutical
- Class Aniline compounds; Peripheral vasodilators; Piperidines
- Mechanism of Action Alpha 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cardiovascular disorders; Intermittent claudication; Raynaud's disease
Most Recent Events
- 09 Oct 2006 Discontinued - Phase-II for Intermittent claudication in USA (unspecified route)
- 09 Oct 2006 Discontinued - Phase-II for Raynaud's disease in USA (unspecified route)
- 09 Oct 2006 Discontinued - Preclinical for Cardiovascular disorders in Japan (unspecified route)